Канал: Pharmatech Associates, a USP company

Richard Steiner DCAT 2023 Improving Sustainability for Pharma Companies

Richard Steiner DCAT 2023 Improving Sustainability for Pharma Companies

Richard Steiner DCAT 2023 Adapting to Shifts in Development Methods Under PCM Adoption

Richard Steiner DCAT 2023 Adapting to Shifts in Development Methods Under PCM Adoption

Richard Steiner DCAT 2023 Different Needs for Different Manufacturers

Richard Steiner DCAT 2023 Different Needs for Different Manufacturers

Richard Steiner DCAT 2023 PCM to Prepare for the Next Wave of Pharma Innovation

Richard Steiner DCAT 2023 PCM to Prepare for the Next Wave of Pharma Innovation

Richard Steiner DCAT 2023 Platforms to Support CDMOs

Richard Steiner DCAT 2023 Platforms to Support CDMOs

Richard Steiner DCAT 2023 Misconceptions about CM

Richard Steiner DCAT 2023 Misconceptions about CM

PCM Measuring Content Uniformity with PAT and RTR in oral solid dose applications

PCM Measuring Content Uniformity with PAT and RTR in oral solid dose applications

mABs Biosimilars from Lab to Clinical

mABs Biosimilars from Lab to Clinical

Mastering Quality Building a Strong Foundation for Your Pharma Startup

Mastering Quality Building a Strong Foundation for Your Pharma Startup

PCM Business Cases Lets Get Specific

PCM Business Cases Lets Get Specific

Modern Approaches to mRNA Manufacturing

Modern Approaches to mRNA Manufacturing

PCM and Regulatory It’s All About the Data

PCM and Regulatory It’s All About the Data

Modern Quality Techniques Patient centric Processes, Integrated QMS, Regulatory Intelligence

Modern Quality Techniques Patient centric Processes, Integrated QMS, Regulatory Intelligence

PCM and Quality Upgrade Your Resolution

PCM and Quality Upgrade Your Resolution

Pharmatech Associates, a USP company Live Stream

Pharmatech Associates, a USP company Live Stream

PCM Equipment Design Bringing the Pieces Together

PCM Equipment Design Bringing the Pieces Together

Cost Savings Related to Qualifying Cell and Gene Therapy Facilities

Cost Savings Related to Qualifying Cell and Gene Therapy Facilities

Richard Steiner shares his perspective on Pharmatech Continuous Manufacturing.

Richard Steiner shares his perspective on Pharmatech Continuous Manufacturing.

PCM: What is the Best Business Strategy for You?

PCM: What is the Best Business Strategy for You?

What You Need to Know About the EU GMP Annex 1 Revision

What You Need to Know About the EU GMP Annex 1 Revision

Quality Considerations for a Robust Data Integrity Program

Quality Considerations for a Robust Data Integrity Program

Driving Cultural Change

Driving Cultural Change

Auditing Alone Does Not Ensure Compliance

Auditing Alone Does Not Ensure Compliance

Quality Managment Maturity Progression

Quality Managment Maturity Progression

Hallmarks of Mature Quality Managment

Hallmarks of Mature Quality Managment

Compliance is More than a Checklist

Compliance is More than a Checklist

An Environment for Mature Quality Management

An Environment for Mature Quality Management

Quality Considerations for Aseptic Processing

Quality Considerations for Aseptic Processing

Applying Process Analytical Technology PAT to Support Real Time Release

Applying Process Analytical Technology PAT to Support Real Time Release

Cell & Gene Therapy Innovations to Drive Down Costs & Increase Efficiency

Cell & Gene Therapy Innovations to Drive Down Costs & Increase Efficiency

The Difference Between Compliance and Quality

The Difference Between Compliance and Quality

2019 ISPE Discovery Stage - Pharmatech Associates

2019 ISPE Discovery Stage - Pharmatech Associates

Medical and Pharmaceutical - Regulatory Compliance and Validation

Medical and Pharmaceutical - Regulatory Compliance and Validation